Press Releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Dec 6, 2021Kamal Will Lead Patient Support to Improve Lives of Cancer Patients
The American Cancer Society (ACS) has hired Dr. Arif Kamal as its first Chief Patient Officer to lead its patient support vision and strategic plans to improve the lives of cancer patients and...
-
Dec 2, 2021Occupational cancer deaths now leading cause of death for fire fighters and EMS personnel
The American Cancer Society (ACS) and the International Association of Fire Fighters (IAFF) today launched an historic, long-term collaboration to help fire fighters and emergency medical services...
-
Nov 23, 2021Initiative focused on increasing awareness of cancer risk, prevention and early detection in the Black community
The American Cancer Society's Partnering For Life initiative will work to spread awareness about cancer risk, prevention, and early detection in the Black community. The initiative will launch...
-
Nov 17, 2021Nation's largest non-government, not-for-profit funder of cancer research announces awards at 59 institutions
The American Cancer Society, the largest non-government, not-for-profit funding source of cancer research in the United States, has approved funding for 82 research and training grants totaling...
-
Nov 16, 2021Donations to BrightEdge fund total $2.5 million; Donors include Wood Next Fund and G2 CEO Godard Abel, serial tech entrepreneur.
The American Cancer Society’s impact investment fund, BrightEdge LLC, today named its first Founder’s Circle members, securing contributions totaling $2.5 million. Launched with an initial $25 million investment from the American Cancer Society (ACS), the mission-driven fund invests in for-profit, early-stage companies developing cutting-edge, cancer-focused therapeutics, diagnostics, devices, and technologies. The impact investment donations are BrightEdge’s first since its formation.